Bipolar disorder, Epilepsy research hub

An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover bioequivalence study comparing Lamotrigine Dispersible Tablets BP 100 mg, manufactured by Sun Pharmaceutical Industries Limited, India with Lamictal (Lamotrigine) Dispersible Tablets 100 mg, Manufactured by: Delpharm Poznaÿ – Poland & Registered and Imported by: GlaxoSmithKline Brasil Ltda, in healthy adult, human subjects under fasting condition.

This study compares two different versions of a medicine called lamotrigine, used for epilepsy and bipolar disorder. Researchers want to see if a new tablet works the same way as an existing one, by giving single doses to healthy adult volunteers.